Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 17 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11673893

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  2. US 11673898

    Substituted inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  3. US 11672774

    Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  4. US 11673896

    Pyridine compounds as allosteric SHP2 inhibitors

    Revolution Medicines, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  5. US 11672793

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  6. US 11672791

    Tyrosine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  7. US 11667643

    RIP1K inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  8. US 11666606

    Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases

    Prime Merger Sub, LLC · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  9. US 11667637

    Fused imidazo-piperidine JAK inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  10. US 11666645

    CD200 inhibitors and methods of use thereof

    Regents of the University of Minnesota · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  11. US 11661426

    Imidazole-containing inhibitors of ALK2 kinase

    BioCryst Pharmaceuticals, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  12. US 11661401

    2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

    Revolution Medicines, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  13. US 11655248

    Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor

    Medshine Discovery Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  14. US 11654157

    Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation

    Shuttle Pharmaceuticals, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  15. US 11654147

    ALK2 inhibitors and methods for inhibiting BMP signaling

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 23, 2023 · Expires May 18, 2043

    granted
  16. US 11654142

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  17. US 11649251

    Substituted inhibitors of menin-MLL and methods of use

    Kura Oncology, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  18. US 11649261

    Crystalline forms of a CD73 inhibitor and uses thereof

    Arcus Biosciences, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  19. US 11649218

    C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 16, 2023 · Expires May 11, 2043

    granted
  20. US 11643388

    Inhibitors of alpha 2 beta 1 integrin and methods of use thereof

    The Regents of the University of California · Granted May 9, 2023 · Expires May 4, 2043

    granted
  21. US 11639364

    Potent sialyltransferase inhibitors

    Stichting Radboud universitair medisch centrum · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  22. US 11639355

    Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors

    Medshine Discovery Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  23. US 11634424

    Diazaindole derivative and use thereof as CHK1 inhibitor

    Medshine Discovery Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  24. US 11634413

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted